Cargando…
Exploration of 4-aminopyrrolo[2,3-d]pyrimidine as antitubercular agents
Tuberculosis (TB) is one of the leading causes of death worldwide. Developing new anti-TB compounds using cost-effective processes is critical to reduce TB incidence and accomplish the End TB Strategy milestone. Herein, we describe the synthesis and structure–activity relationships of a library of t...
Autores principales: | Jesumoroti, Omobolanle Janet, Beteck, Richard M., Jordaan, Audrey, Warner, Digby F., Legoabe, Lesetja J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124159/ https://www.ncbi.nlm.nih.gov/pubmed/35598185 http://dx.doi.org/10.1007/s11030-022-10453-1 |
Ejemplares similares
-
Quinolone-3-amidoalkanol:
A New Class of Potent and
Broad-Spectrum Antimicrobial Agent
por: Dube, Phelelisiwe S., et al.
Publicado: (2023) -
Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010–2020 Review
por: Angula, Klaudia T., et al.
Publicado: (2021) -
Quinolone: a versatile therapeutic compound class
por: Dube, Phelelisiwe S., et al.
Publicado: (2022) -
An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors
por: Moolman, Chantalle, et al.
Publicado: (2020) -
New Quinoline–Urea–Benzothiazole Hybrids as Promising Antitubercular Agents: Synthesis, In Vitro Antitubercular Activity, Cytotoxicity Studies, and In Silico ADME Profiling
por: Moodley, Rashmika, et al.
Publicado: (2022)